| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.26 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |